Biotech RadarJobs updated

COMPANY

ReCor Medical

recormedical.com ↗

FDA-cleared device company

Profile checked Oct 10, 2026

Keywords: Hypertension Vascular Diseases Cardiovascular Diseases Resistant Hypertension Resistant to Conventional Therapy Hypertension PARADISE percutaneous renal denervation Paradise Renal Denervation System Renal Denervation

8Trials (company is sponsor)

Timeline

  1. Trial start —: The RADIANCE CED Study source ↗
  2. Trial start —: Global Paradise System US Post Approval Study source ↗
  3. Trial start Not phased (device or behavioral study): RADIANCE Continued Access Protocol source ↗
  4. Trial start —: The "Global Paradise System" Registry source ↗
  5. Trial start Not phased (device or behavioral study): The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension source ↗
  6. Trial start Not phased (device or behavioral study): A Study of the ReCor Medical Paradise System in Clinical Hypertension source ↗
  7. Trial start Not phased (device or behavioral study): TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE) source ↗
  8. Trial start Not phased (device or behavioral study): REnAL denervatIon by ultraSound Transcatheter Emission source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 8

RecordTitlePhaseStatusStartPrimary completion
NCT03614260The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II HypertensionNot phased (device or behavioral study)Active, not recruitingDec 14, 2018Dec 21, 2022 (actual)
NCT06297291Global Paradise System US Post Approval StudyNot listedRecruitingJun 28, 20242026-09 (estimated)
NCT07231757The RADIANCE CED StudyNot listedRecruitingNov 21, 2025Dec 31, 2029 (estimated)
NCT05027685The "Global Paradise System" RegistryNot listedRecruitingJan 13, 2022Dec 31, 2030 (estimated)
NCT02649426A Study of the ReCor Medical Paradise System in Clinical HypertensionNot phased (device or behavioral study)Active, not recruiting2016-032020-09 (actual)
NCT05017935RADIANCE Continued Access ProtocolNot phased (device or behavioral study)Active, not recruitingMay 4, 2022Dec 31, 2028 (estimated)
NCT01529372REnAL denervatIon by ultraSound Transcatheter EmissionNot phased (device or behavioral study)Completed2012-052015-03 (actual)
NCT01789918TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)Not phased (device or behavioral study)CompletedJan 9, 20132016-03 (actual)
Feedback